See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
DHTV
Popular
Top Rated

Related Medications Videos on Diabetes Health TV

A Product For When You Have Low Blood Sugar

Bill Abajian

A Product For When You Have Low Blood Sugar

Multi-Talented Diabetes Educator Is a Joy to the World

Joy Pape, RN, BSN, CDE, WOCN, CFCN

Multi-Talented Diabetes Educator Is a Joy to the World

Could Byetta Become a Standalone Drug?

Craig Eberhard

Could Byetta Become a Standalone Drug?

Invokana Archives

Invokana

Updated 4 weeks ago
 
FDA Delays Final OK for Type 2 Drug Empagliflozin

The FDA will delay allowing the type 2 drug empagliflozin to enter the U.S. market until "previously observed deficiencies" at the plant where it is manufactured are fixed.

Comments 0 comments - Mar 23, 2014 - * * * * *

Assessing a New Class of Type 2 Drugs

The name alone is a mouthful. Sodium-glucose cotransporter-2 inhibitors are one of the newest class of drugs meant to treat type 2 diabetes, but you can be forgiven if the name doesn't trip lightly off your tongue. The conspicuously vowel-free abbreviation--SGLT2--isn't much better.

Comments 3 comments - Jan 30, 2014 - * * * * *

First-World Type 2 Drug Market to Reach $47 Billion by 2022

A Massachusetts-based research firm concludes that the first-world market for type 2 drugs and treatments will increase from $27 billion in sales in 2012 to $47 billion in 2022.

Comments 0 comments - Oct 18, 2013 - * * * * *

Type 2 Drugs in the Pipeline: an Update

If you Google "type 2 diabetes drugs," one website lists the names of 92 drugs that medical professionals have prescribed at one time or another to treat diabetes.

Comments 0 comments - Sep 17, 2013 - * * * * *

FDA Approves Invokana, a New Type 2 Drug

A new, first-in-its-class drug for type 2 diabetes has just been approved by the Food and Drug Administration. Invokana works by blocking re-absorption of glucose by the kidneys and stimulating urination, which removes glucose from the bloodstream.

Comments 0 comments - Jun 27, 2013 - * * * * *

 
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.